Proceedings of the third international molecular pathological epidemiology (MPE) meeting
Authors:
- Peter T. CampbellPCPeter T. Campbell
- Timothy R. RebbeckTRTimothy R. Rebbeck
- Reiko NishiharaRNReiko Nishihara
- Andrew H. BeckABAndrew H. Beck
- Colin B. BeggCBColin B. Begg
- Alexei A. BogdanovAlexei A. Bogdanov
- Yin CaoYCYin Cao
- Helen G. ColemanHCHelen G. Coleman
- Gordon J. FreemanGFGordon J. Freeman
- Yujing J. HengYHYujing J. Heng
- Curtis HuttenhowerCHCurtis Huttenhower
- Rafael A. IrizarryRIRafael A. Irizarry
- 17 January 2017
- journal article
- review article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 28 (2) , 167-176
Abstract
Molecular pathological epidemiology (MPE) is a transdisciplinary and relatively new scientific discipline that integrates theory, methods, and resources from epidemiology, pathology, biostatistics, bioinformatics, and computational biology. The underlying objective of MPE research is to better understand the etiology and progression of complex and heterogeneous human diseases with the goal of informing prevention and treatment efforts in population health and clinical medicine. Although MPE research has been commonly applied to investigating breast, lung, and colorectal cancers, its methodology can be used to study most diseases. Recent successes in MPE studies include: (1) the development of new statistical methods to address etiologic heterogeneity; (2) the enhancement of causal inference; (3) the identification of previously unknown exposure-subtype disease associations; and (4) better understanding of the role of lifestyle/behavioral factors on modifying prognosis according to disease subtype. Central challenges to MPE include the relative lack of transdisciplinary experts, educational programs, and forums to discuss issues related to the advancement of the field. To address these challenges, highlight recent successes in the field, and identify new opportunities, a series of MPE meetings have been held at the Dana–Farber Cancer Institute in Boston, MA. Herein, we share the proceedings of the Third International MPE Meeting, held in May 2016 and attended by 150 scientists from 17 countries. Special topics included integration of MPE with immunology and health disparity research. This meeting series will continue to provide an impetus to foster further transdisciplinary integration of divergent scientific fields.Keywords
Funding Information
- National Institutes of Health (R13 CA203287)
- National Cancer Institute (R35 CA197735, P30 CA006516)
This publication has 69 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The CpG island methylator phenotype in colorectal cancer: Progress and problemsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Cancer immunology—analysis of host and tumor factors for personalized medicineNature Reviews Clinical Oncology, 2011
- Nutrients in Folate-Mediated, One-Carbon Metabolism and the Risk of Rectal Tumors in Men and WomenNutrition and Cancer, 2011
- Analysis of cohort studies with multivariate and partially observed disease classification dataBiometrika, 2010
- Sufficient cause interactions for categorical and ordinal exposures with three levelsBiometrika, 2010
- Case–Control Study of Overweight, Obesity, and Colorectal Cancer Risk, Overall and by Tumor Microsatellite Instability StatusJNCI: Journal of the National Cancer Institute, 2010
- Aspirin Use and Survival After Diagnosis of Colorectal CancerJAMA, 2009
- Smoking and Colorectal CancerJAMA, 2008